Kim M - Search Results

1

The SxxSS motif of T-cell factor-4 isoforms modulates Wnt/β-catenin signal activation in hepatocellular carcinoma cells.

Tomimaru Y, Koga H, Shin TH, Xu CQ, Wands JR, Kim M. Tomimaru Y, et al. Among authors: kim m. Cancer Lett. 2013 Aug 19;336(2):359-69. doi: 10.1016/j.canlet.2013.03.031. Epub 2013 Apr 2. Cancer Lett. 2013. PMID: 23562475 Free PMC article.

2

Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma.

Merle P, Kim M, Herrmann M, Gupte A, Lefrançois L, Califano S, Trépo C, Tanaka S, Vitvitski L, de la Monte S, Wands JR. Merle P, et al. Among authors: kim m. J Hepatol. 2005 Nov;43(5):854-62. doi: 10.1016/j.jhep.2005.05.018. Epub 2005 Jun 21. J Hepatol. 2005. PMID: 16098625

3

Wnt/Frizzled signaling in hepatocellular carcinoma.

Lee HC, Kim M, Wands JR. Lee HC, et al. Among authors: kim m. Front Biosci. 2006 May 1;11:1901-15. doi: 10.2741/1933. Front Biosci. 2006. PMID: 16368566 Review.

4

Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells.

Kim M, Lee HC, Tsedensodnom O, Hartley R, Lim YS, Yu E, Merle P, Wands JR. Kim M, et al. J Hepatol. 2008 May;48(5):780-91. doi: 10.1016/j.jhep.2007.12.020. Epub 2008 Feb 7. J Hepatol. 2008. PMID: 18313787 Free PMC article.

5

Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration.

Toyama T, Lee HC, Koga H, Wands JR, Kim M. Toyama T, et al. Among authors: kim m. Mol Cancer Res. 2010 Feb;8(2):254-65. doi: 10.1158/1541-7786.MCR-09-0238. Epub 2010 Jan 26. Mol Cancer Res. 2010. PMID: 20103596 Free PMC article.

6

Identification of T-cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells.

Tsedensodnom O, Koga H, Rosenberg SA, Nambotin SB, Carroll JJ, Wands JR, Kim M. Tsedensodnom O, et al. Among authors: kim m. Exp Cell Res. 2011 Apr 15;317(7):920-31. doi: 10.1016/j.yexcr.2011.01.015. Epub 2011 Jan 20. Exp Cell Res. 2011. PMID: 21256126 Free PMC article.

7

Points of therapeutic intervention along the Wnt signaling pathway in hepatocellular carcinoma.

Nambotin SB, Wands JR, Kim M. Nambotin SB, et al. Among authors: kim m. Anticancer Agents Med Chem. 2011 Jul;11(6):549-59. doi: 10.2174/187152011796011019. Anticancer Agents Med Chem. 2011. PMID: 21554202 Review.

8

Loss of the SxxSS motif in a human T-cell factor-4 isoform confers hypoxia resistance to liver cancer: an oncogenic switch in Wnt signaling.

Koga H, Tsedensodnom O, Tomimaru Y, Walker EJ, Lee HC, Kim KM, Yano H, Wands JR, Kim M. Koga H, et al. Among authors: kim km, kim m. PLoS One. 2012;7(6):e39981. doi: 10.1371/journal.pone.0039981. Epub 2012 Jun 29. PLoS One. 2012. PMID: 22768190 Free PMC article.

9

Loss of exon 4 in a human T-cell factor-4 isoform promotes hepatic tumourigenicity.

Tomimaru Y, Xu CQ, Nambotin SB, Yan T, Wands JR, Kim M. Tomimaru Y, et al. Among authors: kim m. Liver Int. 2013 Nov;33(10):1536-48. doi: 10.1111/liv.12189. Epub 2013 May 6. Liver Int. 2013. PMID: 23648141 Free PMC article.

10

Upregulation of T-cell factor-4 isoform-responsive target genes in hepatocellular carcinoma.

Tomimaru Y, Koga H, Yano H, de la Monte S, Wands JR, Kim M. Tomimaru Y, et al. Among authors: kim m. Liver Int. 2013 Aug;33(7):1100-12. doi: 10.1111/liv.12188. Epub 2013 May 8. Liver Int. 2013. PMID: 23651211 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50,935 results

Search Page

Filters